J B Chemicals & Pharmaceuticals Ltd
NSE: JBCHEPHARM BSE: 506943
₹2053.50
(-1.34%)
Tue, 03 Mar 2026, 11:23 pm
Market Cap329.61B
PE Ratio43.28
Dividend0.76
Health Technology
Pharmaceuticals: Major
24.5KJ B Chemicals & Pharmaceuticals Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.43B | 5.17B | 5.67B | 6.73B | 7.29B | 8.72B | 7.76B | 8.46B | 10.01B | 11.21B | 11.71B | 13.13B | 13.87B | 16.02B | 17.39B | 20.03B | 24.03B | 31.30B | 34.68B | 38.92B |
| Gross profit | 827.86M | 1.01B | 2.33B | 2.91B | 3.32B | 4.06B | 2.81B | 2.65B | 3.44B | 3.62B | 3.57B | 3.88B | 4.07B | 5.16B | 5.83B | 7.49B | 8.84B | 11.14B | 13.46B | 14.96B |
| Operating expenses (excl. COGS) | — | -374.82M | -1.82B | -2.27B | -2.16B | -2.54B | -1.99B | -1.95B | -2.39B | -2.19B | -1.82B | -2.27B | -2.59B | -2.94B | -2.92B | -2.93B | -4.24B | -5.30B | -5.91B | -6.49B |
| Selling/general/admin expenses, total | — | — | -1.78B | -2.23B | -1.74B | -2.09B | -1.84B | -1.82B | -2.34B | -2.13B | -2.05B | -2.25B | -2.58B | -2.92B | -2.94B | -2.93B | -4.23B | -5.28B | -5.86B | -6.44B |
| Research & development | — | — | — | — | — | — | — | — | — | — | -221.71M | -260.71M | -322.39M | -333.18M | -251.28M | -258.96M | -304.81M | -355.83M | -356.71M | -448.40M |
| Selling/general/admin expenses, other | — | — | -1.78B | -2.23B | -1.74B | -2.09B | -1.84B | -1.82B | -2.34B | -2.13B | -2.05B | -2.25B | -2.58B | -2.92B | -2.94B | -2.68B | -3.93B | -4.93B | -5.50B | -5.99B |
| Other operating expenses, total | — | -374.82M | -39.41M | -35.57M | -424.79M | -447.08M | -144.77M | -127.86M | -53.71M | -54.12M | 224.41M | -16.81M | -15.42M | -14.52M | 20.00M | 4.17M | -4.33M | -18.28M | -48.19M | -57.95M |
| Operating income | 752.01M | 638.94M | 503.17M | 639.91M | 1.16B | 1.52B | 818.82M | 699.62M | 1.05B | 1.43B | 1.75B | 1.61B | 1.48B | 2.22B | 2.91B | 4.56B | 4.60B | 5.85B | 7.55B | 8.46B |
| Non-operating income, total | 59.20M | 60.60M | -77.83M | -282.67M | 318.19M | 130.46M | 7.62B | 336.13M | -176.48M | 21.64M | 374.24M | 688.20M | 463.17M | 645.74M | 579.80M | 1.41B | 444.25M | -292.72M | -33.84M | 412.60M |
| Interest expense, net of interest capitalized | -53.98M | -112.49M | -180.32M | -151.66M | -90.68M | -73.73M | -98.18M | -52.81M | -62.29M | -68.24M | -106.46M | -34.66M | -26.78M | -37.40M | -31.32M | -67.05M | -39.72M | -347.29M | -436.51M | -106.91M |
| Interest capitalized | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 113.18M | 173.08M | 102.49M | -125.85M | 413.05M | 200.01M | 7.71B | 388.93M | 352.72M | 88.14M | 452.43M | 756.15M | 657.09M | 502.40M | 579.95M | 1.07B | 471.35M | 18.88M | 233.06M | 460.90M |
| Non-operating interest income | 7.04M | 22.94M | 3.48M | 17.60M | 17.64M | 31.42M | 85.59M | 24.51M | 13.21M | 13.31M | 11.72M | 11.79M | 16.75M | 22.96M | 26.21M | 17.74M | 9.34M | 25.36M | 44.26M | 53.26M |
| Miscellaneous non-operating expense | 106.14M | 150.15M | 99.01M | -143.45M | 395.42M | 168.59M | 7.63B | 364.42M | 339.51M | 74.83M | 426.56M | 744.36M | 631.55M | 472.58M | 544.62M | 1.04B | 444.81M | -22.03M | 176.84M | 395.09M |
| Unusual income/expense | — | — | — | -5.16M | -4.19M | 4.18M | 2.00K | — | -466.91M | 1.74M | 28.27M | -33.30M | -167.14M | 180.74M | 31.17M | 406.92M | 12.62M | 35.69M | 169.61M | 58.62M |
| Pretax income | 811.21M | 699.54M | 425.34M | 357.24M | 1.48B | 1.65B | 8.43B | 1.04B | 874.45M | 1.46B | 2.12B | 2.30B | 1.94B | 2.87B | 3.49B | 5.97B | 5.05B | 5.55B | 7.52B | 8.87B |
| Taxes | -108.84M | -77.07M | 27.87M | -100.14M | -292.20M | -259.16M | -1.66B | -241.31M | -259.49M | -451.43M | -495.81M | -455.46M | -552.31M | -930.23M | -765.00M | -1.48B | -1.19B | -1.45B | -1.99B | -2.28B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.04M | -3.35M | -3.79M | -5.03M | -3.45M | -5.59M | -6.82M | -1.70M | 0 | 0 |
| After tax other income/expense | — | — | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 702.37M | 621.77M | 453.20M | 257.10M | 1.19B | 1.39B | 6.78B | 794.44M | 614.96M | 1.00B | 1.63B | 1.84B | 1.38B | 1.93B | 2.72B | 4.48B | 3.85B | 4.10B | 5.53B | 6.60B |
| Net income | 702.37M | 621.77M | 453.20M | 257.10M | 1.19B | 1.39B | 6.78B | 794.44M | 614.96M | 1.00B | 1.63B | 1.84B | 1.38B | 1.93B | 2.72B | 4.48B | 3.85B | 4.10B | 5.53B | 6.60B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 702.37M | 621.77M | 453.20M | 257.10M | 1.19B | 1.39B | 6.78B | 794.44M | 614.96M | 1.00B | 1.63B | 1.84B | 1.38B | 1.93B | 2.72B | 4.48B | 3.85B | 4.10B | 5.53B | 6.60B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 859.33M | 752.32M | 672.18M | 844.24M | 1.38B | 1.75B | 1.04B | 946.20M | 1.33B | 1.82B | 2.16B | 2.08B | 2.05B | 2.78B | 3.57B | 5.24B | 5.33B | 6.99B | 8.93B | 10.17B |
| EBIT | 752.01M | 638.94M | 503.17M | 639.91M | 1.16B | 1.52B | 818.82M | 699.62M | 1.05B | 1.43B | 1.75B | 1.61B | 1.48B | 2.22B | 2.91B | 4.56B | 4.60B | 5.85B | 7.55B | 8.46B |
| Total operating expenses | -3.68B | -4.53B | -5.17B | -6.09B | -6.12B | -7.19B | -6.94B | -7.76B | -8.96B | -9.78B | -9.96B | -11.52B | -12.40B | -13.80B | -14.48B | -15.48B | -19.42B | -25.45B | -27.13B | -30.46B |
| Prepaid expenses | — | — | 64.89M | 66.13M | 12.92M | 26.37M | 29.73M | 96.59M | — | — | 3.66B | 51.23M | 72.80M | 107.65M | 79.82M | 122.56M | 120.40M | 167.04M | 163.23M | 190.14M |
| Deferred income, current | — | — | — | — | — | — | — | — | 6.54M | 2.43M | 6.36M | 37.27M | 76.47M | 127.54M | 137.02M | 26.08M | 43.15M | 120.91M | 129.86M | 103.23M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.29M | 51.41M | 51.41M | 206.18M | 153.21M | 96.38M | 63.53M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 184.90M | 190.74M | 195.49M | 142.69M | 144.02M | 230.90M | 297.54M | 192.55M | 290.30M | 545.74M | 668.07M | 692.75M | 772.18M | 640.89M | 721.26M | 603.08M | 1.14B | 1.66B | 2.00B |
| Deferred income, non-current | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.65M | 21.80M | 27.72M | 28.03M | 25.01M | 37.05M | 44.90M | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -228.44M | -249.57M | -147.97M | -49.62M | -98.36M | -196.54M | -4.12B | -99.86M | -298.35M | -297.21M | -1.88B | -57.39M | -103.35M | -207.94M | -1.41B | -732.40M | -1.28B | -1.28B | -1.57B | -2.37B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800